|
|
Entest Bio Medical marketed by David Cohen
|
|
Posted On :
Apr-01-2010
| seen (533) times |
Article Word Count :
534
|
|
Entest Bio Medical (known as ENTB) is a medical research company involved in developing and testing certain aspects of diabetes, treatment of diabetes and development of medical devices for the same.
|
|
Entest Bio Medical (known as ENTB) is a medical research company involved in developing and testing certain aspects of diabetes, treatment of diabetes and development of medical devices for the same. The value of ENTB stock has advanced at an astonishing rate thanks to the help of Stock Professional David Cohen and his newsletter. ENTB hired David Cohen and his team at Research Driven Investor (RDI) to promote their company, increase the value of their stock as well as increase the liquidity within their company. During a three month period ENTB went from having stocks worth just 0.53 to having them value 1.70. Prior to hiring David Cohen the company had never been promoted.
The expertise of David and his team at RDI used a combination of newsletter releases, forum and blog postings, CEO casts, as well as advertising in all major search engines in order to drive the stocks of ENTB from 0.53 up to 1.00+ before any other newsletter became involved in promoting the company. At present the stock is sitting at 2.00 which means that some investors are seeing triple digit profits proving that David Cohen and his reputation is nothing but factual.
David Cohen and his team at RDI publish the most amazing penny stock newsletter available. For a total 17 years and running, his newsletter has lead the industry. They have already provided subscriptions to over 27,000 people. Subscribers have declared David Cohen to be one of the most respected financial newsletters available to subscribers in CN, North America and the UK. He offers a free trial subscription that gains subscribers instant access to the current newsletter as well as all of the other important media that he offers including current stock picks, buy and sell prices and much more. All of these are updated every few days, if not daily.
ENTB stock is just one of the many, great examples of what David Cohen is able to help a company achieve. His experience in stocks is extensive and has allowed him to gain the much needed knowledge which is required in order to develop the approach he has been using to successfully provide his subscribers with recommendations that work time and time again. Along the way David has learned that researching stocks for his subscribers is crucial. By providing only perfectly fitting stocks to the investors and coordinating timely news releases during only the best timing within the market, he is able to gain the highest possible visibility for both exposure and gains of the investors.
Companies like ENTB hire David Cohen and his team at Research Driven Inspector because of his superb track record in the industry as well as an astonishing amount of positive reviews written by previous or current subscribers who has saw profits by using his newsletter. Companies know that he has developed an approach that works due to his use of both fundamental and technical analysis and his method of using only the most valuable aspects needed to achieve his goal. ENTB is only one of many companies who have used David Cohen and have doubled or even tripled their stock value over a short period of time.
|
|
|
|
Article Source :
http://www.articleseen.com/Article_Entest Bio Medical marketed by David Cohen_15279.aspx
|
|
Author Resource :
The author of this article has expertise in sending out penny stock newsletter. The articles on small cap investors reveals the author’s knowledge on the same. With the knowledge the author offers stock recommendations as well.
|
|
Keywords :
stock newsletter, penny stocks, penny stock picks, stock recommendations, trade recommendations, stock picks, investors, smal,
Category :
Finance
:
Finance
|
|
|
|
|
|
